Effectiveness of a clinimetric scale for diagnosing vulvovaginal candidosis;Eficacia de un instrumento clinimétrico en el diagnóstico de candidiasis vulvovaginal

Ginecologia y Obstetricia de Mexico

Volumn 72, Issue 5, 2004, Pages 219-226

  Figueroa, Jesús Reyna ^a   Rangel, Verónica Morales ^a   Ibarra, Federico Javier Ortiz ^a   Román, Gerardo Casanova ^a   Zúñiga, Magdalena Beltrán ^a  

^a INSTITUTO NACIONAL DE PERINATOLOGÍA   (Mexico)

Author keywords

Cervicovaginitis; Clinimetric; Diagnosis; Vulvovaginal candidosis

Indexed keywords

ADULT; ARTICLE; CANDIDA ALBICANS; CONSENSUS; DIABETES MELLITUS; EDEMA; FISHER EXACT TEST; HUMAN; PRURITUS; SENSITIVITY ANALYSIS; VAGINA CANDIDIASIS; BIOMETRY; FEMALE; QUESTIONNAIRE; REPRODUCIBILITY; RISK FACTOR; SENSITIVITY AND SPECIFICITY;

BIOMETRY; CANDIDIASIS, VULVOVAGINAL; FEMALE; HUMANS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 4844221357     PISSN: 03009041     EISSN: 03009041     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Narcio RM. Etiología de la infección cervicovaginal en pacientes embarazadas y no embarazadas. Ginecol Obstet Mex 1989;57:41-46.
2. rd ed. New York: Mc-Graw Hill, 1990;pp:629-40.
3. Casanova. GR, Utilidad del examen en fresco para el diagnóstico de candidiasis vaginal. Ginecol Obstet Mex 1997;65:87-91.
4. Ware ES, Donald SC. The Mos 36- ITEM Short-form Health Survey (SF-36). Med Care 1992;30:473-83.
5. Cluffle R. Chronic disease function and the quality of care. J Chronic Dis 1981;34:299.
6. Ellwood PM. Outcomes management: a technology of patient experience. N Engl J Med 1988;318:1549.
7. American Cancer Society. Proceedings of the working conference on methodology in behavioral and psychological cancer research 1983. Cancer 1984;S3(Supp1):2217.
8. Lohr KN, Ware JE. Advances in health assessment. J Chronic Dis 1987;40(Supp1):15.
9. Harold C. The infrequent use of office-based diagnostic tests for vaginitis. Am J Obstet Gynecol 1999;181:39-41.
10. Feinstein AR. Clinimetrics. New Haven, CT: Yale University Press, 1987.
11. Armstrong GE. Infectious diseases. Vaginitis, vulvitis and cervicitis. Baltimore: Ossmond Press, 1998;pp:52-54.
12. Gorka B. Vulvovaginitis candidiasis. Rev Iberoam Micol 2002;19:22-24.
13. Giraldo P. Vaginal colonization by Candida in asymptomatic women with and without a history of recurrent vulvovaginal candidiasis. Obstet Gynecol 2000;95:413-6.
14. CDC. Sexually transmitted diseases treatment guidelines 2002. MMWR 2002;51:p:45.
15. Sobel JD. Vulvovaginal candidiasis. Sem Dermatol 1996;15:17-28.
16. Sinikka S. Self-medication with vaginal antifungal drugs: physician experiences and women's utilization patterns. Fam Pract 2000;17(2):145-9.
17. Wenger NK, Mattson ME, Furberg CD. Assessment of quality of life in clinical trials of cardiovascular therapies. New York: Le Jacq Publishing, 1984.
18. Lohr KN. Advances in health assessment: Overview of the conference. Med Care 1989;27:3.
19. Eckert LO. Vulvovaginal candidiasis: Clinical manifestations, risk factors, management algorithm. Obstet Gynecol 1998;92:757-65.